Search

everythinglearnresearchcommunity

for

Search:↓

Ovarian vein sampling helped diagnose rare ovarian tumors causing high testosterone, and surgery to remove the tumors lowered the testosterone levels.

A woman with hair loss condition experienced rare hair color return, suggesting it might help diagnose the condition.

Postmenopausal women often experience hair loss on the scalp and increased facial hair, but iron supplements may not help.

PCOS is diagnosed when at least two of these three features are present: polycystic ovaries, irregular ovulation, and high androgen levels.

Hair levels of estradiol and progesterone are higher in premenopausal than postmenopausal women, but the difference isn't statistically significant, indicating the need for a better measurement method.

Reticulocyte hemoglobin content is the best indicator of iron deficiency in women with diffuse non-scarring hair loss.

Estrogen helps improve skin aging and healing, especially in post-menopausal women.

Over-the-counter hair growth products may cause frontal fibrosing alopecia due to allergens.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Most women had adequate essential elements except zinc, and lead levels were higher in peri-/post-menopausal women.

Ovarian hyperthecosis caused high testosterone and virilization symptoms in a 60-year-old woman, which improved after surgery.

Higher GPER-1 levels are linked to more severe and shorter-duration androgenetic alopecia, suggesting GPER-1 as a potential treatment target.

Acne can appear or persist in adulthood due to hormonal changes, external factors, or substance use, and requires appropriate treatment.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Female pattern hair loss treatments vary in effectiveness and may have side effects.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Iron deficiency is linked to female pattern hair loss.

Gender affects hair and scalp characteristics, with differences in hormone responses, graying patterns, and trace metals.

Hormones, especially androgens, play a key role in causing acne, and treatments like hormone control pills and hormone-blocking medications can help.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Testosterone therapy is effective and safe for women with low sexual desire, but it's hard to access.

Spironolactone is effective for treating female hair loss, with new treatments like clascoterone showing promise.

Hair greying is seen as a sign of aging; temporary fixes like hair dye are used, but a balanced diet and hair care can help manage it.

A 66-year-old woman with skin lesions and other symptoms improved after treatment for porphyria cutanea tarda.

Balanced hormones are crucial for women's health, and can be managed with lifestyle changes or hormone therapy if needed.

Topical finasteride works faster and better than 17α-estradiol for postmenopausal hair loss.

Biosea® Revive Serum is safe and effective for improving hair growth and health.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.